Presentation to international porphyria patient group

8 February 2016

Clinuvel Pharmaceuticals Ltd (ASX: CUV; XETRA‐DAX: UR9; ADR: CLVLY) presented to an international porphyria patient meeting, held in Rotterdam, the Netherlands, on February 6, 2016. The presentation and speaking notes are appended to this announcement.